Catálogo de publicaciones - libros

Palabras clave – provistas por la editorial

n/a; FOLFIRINOX; immunofluorescence imaging; AR-V7; circulating tumour cells; chemoradioresistance; CTC-based treatment decisions; rVAR2; immunophenotyping; immune system; CellSearch®; flow cytometry; clinical trials; circulating tumor DNA; synaptophysin; stem cells; colorectal cancer; melanoma; CTC biology; platelets; AR; CTC capture technology; castration resistant prostate cancer (CRPC); PD-L1 expression; rovalpituzumab tesirine; HMB-45; thymidylate synthase; ctDNA; tumor cell dissemination; solid cancers; metastasis; locally advanced rectal cancer; miRNA; epithelial-to-mesenchymal transition (EMT); NSCLC; tumor biomarkers; tumor stem cells; circulating tumor cells; major histocompatibility complex class I (MHCI); bone marrow; heterogeneity; cerebrospinal liquid biopsy; fish; glioma; in vivo flow cytometry; colorectal surgery; CellSearch; single-cell analysis; disseminated tumor cells; EasyCount slides; microsatellite instability; circulating plasma cells; circulating leukemia cells; ARV7; SLUG; androgen receptor; metastatic colorectal cancer; leukocyte-derived extracellular vesicles; prostate cancer (PCa); neutrophils; liquid biopsy; enzalutamide; CD133; enrichment and detection technologies; biomarkers; immune checkpoint inhibitors; biomarker; RAD23B; microbiome; integrin B1; ACCEPT; emboli; small-cell lung carcinoma; EPISPOT; microfluidics; early breast cancer; circulating tumor cells (CTC); tumor-initiating cells (TICs); immunomodulation; xenograft models; CTC-derived xenografts; malaria; circulating tumor cells (CTCs); clinical utility; exosomes; liquid surgery; ctRNA; CTCs; epithelial–mesenchymal transition; targeted therapy; hematological cells; gene expression analysis; hepatocellular carcinoma (HCC); breast cancer; EpCAM enrichment; prostate cancer; CTC; abiraterone; fibronectin; CTC-derived ex vivo models; CTMat; chromogranin A; CTM; exosome